Delivery Order SPE2DB20D1004-SPE2DB21FF6F1
- Not listed
- The federal contract award is for a Delivery Order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" with a ceiling value of $1,156.26. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is a delivery order worth $5,483.55 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for a "Prime Vendor Pharm Branch-Philadelphia" and does not have a set-aside designation, indicating open competition. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order worth $1,311.38 for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" from the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for a Prime Vendor Pharmaceutical contract with the Defense Logistics Agency (DLA) valued at $7,181.84. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal...
- This federal contract award is for a Delivery Order valued at $2,321.82, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for prime vendor pharmaceutical support, providing a broad range of medical products including specialty medications, generic and brand-name drugs, vaccines, syringes, vials, and other critical care supplies. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) for the provision of prime vendor pharmaceutical products and medical supplies. The contract, valued at $2,567.00, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award from the Defense Logistics Agency (DLA) is for a Prime Vendor Pharmaceutical Branch-Philadelphia delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,401.60 fixed-price contract provides a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities and veteran healthcare programs....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,764.06 for the supply of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $4,722.50 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care items. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The federal contract award is for a prime vendor pharmaceutical contract with the Defense Logistics Agency (DLA) awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,710.00 and is a firm fixed price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has an Indefinite Delivery Contract (IDC) with...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB21FF6F1Delivery Order
This federal contract award is for a delivery order with a ceiling value of $2,814.46, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for a "Prime Vendor Pharm Branch-Philadelphia" and covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical medical commodities. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 5/26/21 |